ClinicalTrials.Veeva

Menu

BD-Covered Stent for Benign Esophageal Strictures: a Safety and Feasibility Study (BIDARCA)

R

Radboud University Medical Center

Status

Unknown

Conditions

Benign Esophageal Stricture

Treatments

Device: BD-Covered esophageal stent

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT03189927
NL.59222.091.16

Details and patient eligibility

About

A non-randomized prospective clinical, pilot study in a single centre assessing the safety and feasibility of the esophageal biodegradable covered stent for refractory benign esophageal strictures with or without fistulae

Full description

A non-randomized prospective clinical, pilot study in a single centre assessing the safety and feasibility of the esophageal biodegradable covered stent for refractory benign esophageal strictures with or without fistulae. The follow-up will be 6 months form implantation. After 3 months a control endoscopy will take place to evaluate stent and degradation process.

Enrollment

15 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjects of both genders
  • Age ≥ 18 years
  • Appropriate cultural level and understanding of the study
  • Willingness to participate voluntarily in the study and give written informed consent
  • Refractory benign esophageal stricture with or without fistulae, i.e. the patient has to pass a minimum of 2 and a maximum of 10 failed esophageal dilations to the minimal diameter of 15-mm, using a pneumatic balloon dilator or Savary bougie, not complicated by or malignancy.
  • Ability to undergo periodic endoscopic follow-up.

Exclusion criteria

  • Pregnancy or breastfeeding
  • Simultaneous participation in another clinical study
  • Life expectancy of less than 12 months
  • Malignant esophageal stricture
  • Stenosis after laryngectomy, or if the distance between the upper edge of the stent is less than 2 cm from the upper esophageal sphincter
  • Undergone an esophageal stent implantation before.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

15 participants in 1 patient group

BD-Covered stent
Experimental group
Description:
Device: BD-Covered stent for refractory benign esophageal strictures with of without fistulae
Treatment:
Device: BD-Covered esophageal stent

Trial contacts and locations

0

Loading...

Central trial contact

Bram Vermeulen, Drs.; Peter SiersemA, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems